Compare CVS Health Corp (CVS) vs YieldMax AI & Tech Portfolio Option Income ETF (GPTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs YieldMax AI & Tech Portfolio Option Income ETF — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while YieldMax AI & Tech Portfolio Option Income ETF trades at $42.7. The key difference: CVS Health Corp pays a 2.78% dividend while YieldMax AI & Tech Portfolio Option Income ETF pays none, and CVS Health Corp is trading nearer its 52-week high, YieldMax AI & Tech Portfolio Option Income ETF nearer its low. Which is the better fit depends on your goals.
| CVS | GPTY | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $110.60 | $50.52 |
52-Week Low | $65.51 | $34.73 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
GPTY trades at $42.64, up 0.94% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF focuses on AI and tech equities, using options strategies to generate weekly dividends, with recent payouts ranging from $0.28 to $0.37. Support and resistance levels are clustered around $41-$43, indicating tight trading ranges.
Outlook is supported by AI theme momentum and income generation, but risks include semiconductor concentration and NAV erosion from options strategies. Investor sentiment is mixed, with some analysts highlighting yield sustainability concerns versus exposure benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About YieldMax AI & Tech Portfolio Option Income ETF
GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Read more on GPTY →
